CENTOGENE Completes Strategic Deal with Private Equity Firm Charme Capital Partners

Centogene N.V. Announces Sale of Operating Subsidiaries to Charme Capital Partners On March 12, 2025, Centogene N.V. (CENTOGENE), a leading genetic testing and analysis company, announced the completion of the transaction to sell its operating subsidiaries to an affiliate of Charme Capital Partners Limited (Charme). This strategic move is aimed at accelerating Centogene’s growth and…

Read More

Innovative, Articulate, and Easy to Follow: A Professional Flair in Celsius Network’s $1 Billion ETH Sale to CEXs – How Will the Market Respond?

Celsius Network Sells Over $1 Billion Worth of ETH to CEXs, How Will the Market React? Celsius Network’s ETH Tsunami: Whales Sweep Over $1 Billion Through Exchanges Celsius Network is currently in bankruptcy and has been moving massive amounts of Ethereum (ETH) to Coinbase Prime, Paxos, and FalconX, shocking the cryptocurrency world. Spotonchain report suggests…

Read More

“Calling All AZN Shareholders: Don’t Miss Out on Potential Compensation for Your Losses with AstraZeneca PLC!”

Are you a victim of investment loss on AstraZeneca PLC? Seeking potential recovery under federal securities laws NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the…

Read More